Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Natural Product Synthesis. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113735894A discloses a chromium-catalyzed method for synthesizing chiral 2,3-allenols with dual chirality, offering cost reduction in API manufacturing and scalable production.
Novel convergent synthesis of Penicillide racemate using commercially available starting materials. High yield, scalable route for API intermediates.
Patent CN117069732B details a high-purity synthesis route for benzo[c]phenanthridine alkaloids, offering supply chain reliability and cost-effective manufacturing for global pharmaceutical partners.
Patent CN116217572A details a novel cobalt-catalyzed route to [6.5.5] indoline derivatives, offering significant cost reduction in API manufacturing and simplified supply chains.
Discover a novel L-glutamic acid route for multi-chiral tetrahydrofuran rings. High stereoselectivity and mild conditions for cost-effective API manufacturing.
Patent CN115286608A reveals a high-yield, base-catalyzed route for benzopyran compounds, offering cost reduction in pharmaceutical intermediate manufacturing and superior functional group tolerance.
Patent CN10494545451B reveals high-yield glycosylation route. Eliminates heavy metals for cost reduction and supply reliability in pharmaceutical intermediate manufacturing.
Novel Ru-catalyzed C-H activation method for benzofuran acids. Green oxidant, scalable process for API intermediates and natural products like diptoindonesin G.
Novel route for ETP natural product Epicoccin G using photo-oxidation and dimerization. Cost-effective scale-up for pharmaceutical intermediates.
Discover the efficient 5-step synthesis of (-)-newbouldine via FeCl3 catalysis. A reliable supplier solution for high-purity pharmaceutical intermediates with reduced toxicity.
Patent CN107129462B details a novel total synthesis of Rupestine G via RCM. We offer scalable manufacturing, cost reduction, and high-purity pharmaceutical intermediates.
Patent CN113735894B details a Cr-catalyzed route to chiral 2,3-allenols. Offers high enantioselectivity and scalable conditions for API intermediates.
Patent CN112694430B details a safe, high-yield palladium-catalyzed carbonylation route for bioactive pyrrolone scaffolds, offering significant supply chain advantages.
Novel cobalt-catalyzed asymmetric Friedel-Crafts reaction for high-purity oxindoles. Cost-effective alternative to noble metals with scalable production capabilities.
Recent patent literature demonstrates a Ni(II)-catalyzed one-step synthesis of 3-ether isoindolinone intermediates with 88-98% yield, enabling cost reduction in API manufacturing and supply chain stability.
Solve azacyclooctanofuranone synthesis challenges with iron-catalyzed one-pot method. Reduce costs, improve yield, and ensure green production for pharma R&D and procurement teams.
Solve C-S bond formation challenges with air-stable indole phosphine ligands. 0.5 mol% catalyst, 90% yield. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.
Solve pyrrole synthesis challenges with 82% yield, mild conditions, and flexible aryl substitution for pharmaceutical intermediates. Reduce supply chain risks now.
Discover how water-based bromide/persulfate synthesis of 3-hydroxyisoindol-1-one reduces metal residues, eliminates organic solvents, and cuts production costs for pharmaceutical intermediates.
Discover a one-step palladium-catalyzed method for pyrrole fused-ring 3-indolone synthesis with 63% yield. Eliminate CO gas risks and complex post-treatment. Scale to 100 MT/yr with NINGBO INNO PHARMCHEM.